Involvement of Arterial Stiffness and Inflammation in Hyperuricemia-Related Development of Hypertension
This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension (ie, increased arterial stiffness, renal dysfunction, and inflammation), and then examined whether these risk factors show longitudina...
Saved in:
Published in | Hypertension (Dallas, Tex. 1979) Vol. 72; no. 3; pp. 739 - 745 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Heart Association, Inc
01.09.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension (ie, increased arterial stiffness, renal dysfunction, and inflammation), and then examined whether these risk factors show longitudinal associations with the development of hypertension. In 3274 Japanese men without hypertension, the brachial-ankle pulse wave velocity, blood pressure, estimated glomerular filtration rate, and serum uric acid and CRP (C-reactive protein) levels were measured annually over an 8-year period. Of these, 474 subjects developed hypertension by the end of the study period. Mixed model linear regression analysis revealed a significant longitudinal association of hyperuricemia with increase of the brachial-ankle pulse wave velocity (estimate=5.50, P=0.04), decrease of the estimated glomerular filtration rate (estimate=−2.02, P<0.01), and elevation of the CRP (estimate=0.08×10, P=0.02). Hyperuricemia at the study baseline was associated with a significant odds ratio for the development of hypertension by the end of the study period. After adjustments for covariates, the brachial-ankle pulse wave velocity (estimate=0.51×10, P<0.01) and CRP (estimate=1.91, P=0.03), but not estimated glomerular filtration rate, were found to show independent longitudinal associations with the new onset of hypertension. In Japanese men without hypertension, hyperuricemia may have a longitudinal association with the development of hypertension, and increased arterials stiffness and inflammation may be involved in the risk of development of hypertension associated with hyperuricemia. |
---|---|
AbstractList | This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension (ie, increased arterial stiffness, renal dysfunction, and inflammation), and then examined whether these risk factors show longitudinal associations with the development of hypertension. In 3274 Japanese men without hypertension, the brachial-ankle pulse wave velocity, blood pressure, estimated glomerular filtration rate, and serum uric acid and CRP (C-reactive protein) levels were measured annually over an 8-year period. Of these, 474 subjects developed hypertension by the end of the study period. Mixed model linear regression analysis revealed a significant longitudinal association of hyperuricemia with increase of the brachial-ankle pulse wave velocity (estimate=5.50, P=0.04), decrease of the estimated glomerular filtration rate (estimate=-2.02, P<0.01), and elevation of the CRP (estimate=0.08×10-1, P=0.02). Hyperuricemia at the study baseline was associated with a significant odds ratio for the development of hypertension by the end of the study period. After adjustments for covariates, the brachial-ankle pulse wave velocity (estimate=0.51×10-2, P<0.01) and CRP (estimate=1.91, P=0.03), but not estimated glomerular filtration rate, were found to show independent longitudinal associations with the new onset of hypertension. In Japanese men without hypertension, hyperuricemia may have a longitudinal association with the development of hypertension, and increased arterials stiffness and inflammation may be involved in the risk of development of hypertension associated with hyperuricemia.This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension (ie, increased arterial stiffness, renal dysfunction, and inflammation), and then examined whether these risk factors show longitudinal associations with the development of hypertension. In 3274 Japanese men without hypertension, the brachial-ankle pulse wave velocity, blood pressure, estimated glomerular filtration rate, and serum uric acid and CRP (C-reactive protein) levels were measured annually over an 8-year period. Of these, 474 subjects developed hypertension by the end of the study period. Mixed model linear regression analysis revealed a significant longitudinal association of hyperuricemia with increase of the brachial-ankle pulse wave velocity (estimate=5.50, P=0.04), decrease of the estimated glomerular filtration rate (estimate=-2.02, P<0.01), and elevation of the CRP (estimate=0.08×10-1, P=0.02). Hyperuricemia at the study baseline was associated with a significant odds ratio for the development of hypertension by the end of the study period. After adjustments for covariates, the brachial-ankle pulse wave velocity (estimate=0.51×10-2, P<0.01) and CRP (estimate=1.91, P=0.03), but not estimated glomerular filtration rate, were found to show independent longitudinal associations with the new onset of hypertension. In Japanese men without hypertension, hyperuricemia may have a longitudinal association with the development of hypertension, and increased arterials stiffness and inflammation may be involved in the risk of development of hypertension associated with hyperuricemia. This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension (ie, increased arterial stiffness, renal dysfunction, and inflammation), and then examined whether these risk factors show longitudinal associations with the development of hypertension. In 3274 Japanese men without hypertension, the brachial-ankle pulse wave velocity, blood pressure, estimated glomerular filtration rate, and serum uric acid and CRP (C-reactive protein) levels were measured annually over an 8-year period. Of these, 474 subjects developed hypertension by the end of the study period. Mixed model linear regression analysis revealed a significant longitudinal association of hyperuricemia with increase of the brachial-ankle pulse wave velocity (estimate=5.50, P=0.04), decrease of the estimated glomerular filtration rate (estimate=−2.02, P<0.01), and elevation of the CRP (estimate=0.08×10, P=0.02). Hyperuricemia at the study baseline was associated with a significant odds ratio for the development of hypertension by the end of the study period. After adjustments for covariates, the brachial-ankle pulse wave velocity (estimate=0.51×10, P<0.01) and CRP (estimate=1.91, P=0.03), but not estimated glomerular filtration rate, were found to show independent longitudinal associations with the new onset of hypertension. In Japanese men without hypertension, hyperuricemia may have a longitudinal association with the development of hypertension, and increased arterials stiffness and inflammation may be involved in the risk of development of hypertension associated with hyperuricemia. This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension (ie, increased arterial stiffness, renal dysfunction, and inflammation), and then examined whether these risk factors show longitudinal associations with the development of hypertension. In 3274 Japanese men without hypertension, the brachial-ankle pulse wave velocity, blood pressure, estimated glomerular filtration rate, and serum uric acid and CRP (C-reactive protein) levels were measured annually over an 8-year period. Of these, 474 subjects developed hypertension by the end of the study period. Mixed model linear regression analysis revealed a significant longitudinal association of hyperuricemia with increase of the brachial-ankle pulse wave velocity (estimate=5.50, P =0.04), decrease of the estimated glomerular filtration rate (estimate=−2.02, P <0.01), and elevation of the CRP (estimate=0.08×10 −1 , P =0.02). Hyperuricemia at the study baseline was associated with a significant odds ratio for the development of hypertension by the end of the study period. After adjustments for covariates, the brachial-ankle pulse wave velocity (estimate=0.51×10 −2 , P <0.01) and CRP (estimate=1.91, P =0.03), but not estimated glomerular filtration rate, were found to show independent longitudinal associations with the new onset of hypertension. In Japanese men without hypertension, hyperuricemia may have a longitudinal association with the development of hypertension, and increased arterials stiffness and inflammation may be involved in the risk of development of hypertension associated with hyperuricemia. This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension (ie, increased arterial stiffness, renal dysfunction, and inflammation), and then examined whether these risk factors show longitudinal associations with the development of hypertension. In 3274 Japanese men without hypertension, the brachial-ankle pulse wave velocity, blood pressure, estimated glomerular filtration rate, and serum uric acid and CRP (C-reactive protein) levels were measured annually over an 8-year period. Of these, 474 subjects developed hypertension by the end of the study period. Mixed model linear regression analysis revealed a significant longitudinal association of hyperuricemia with increase of the brachial-ankle pulse wave velocity (estimate=5.50, P=0.04), decrease of the estimated glomerular filtration rate (estimate=-2.02, P<0.01), and elevation of the CRP (estimate=0.08×10 , P=0.02). Hyperuricemia at the study baseline was associated with a significant odds ratio for the development of hypertension by the end of the study period. After adjustments for covariates, the brachial-ankle pulse wave velocity (estimate=0.51×10 , P<0.01) and CRP (estimate=1.91, P=0.03), but not estimated glomerular filtration rate, were found to show independent longitudinal associations with the new onset of hypertension. In Japanese men without hypertension, hyperuricemia may have a longitudinal association with the development of hypertension, and increased arterials stiffness and inflammation may be involved in the risk of development of hypertension associated with hyperuricemia. |
Author | Iwasaki, Yoichi Chikamori, Taishiro Matsumoto, Chisa Fujii, Masatsune Tomiyama, Hirofumi Shiina, Kazuki Kimura, Kazutaka Vlachopoulos, Charalambos Yamashina, Akira |
AuthorAffiliation | From the Department of Cardiology and Division of Preemptive Medicine for Vascular Damage, Tokyo Medical University, Japan (H.T., K.S., Y.I., C.M., K.K., M.F., T.C., A.Y.) 1st Cardiology Department, Athens Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Greece (C.V.) |
AuthorAffiliation_xml | – name: From the Department of Cardiology and Division of Preemptive Medicine for Vascular Damage, Tokyo Medical University, Japan (H.T., K.S., Y.I., C.M., K.K., M.F., T.C., A.Y.) 1st Cardiology Department, Athens Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Greece (C.V.) |
Author_xml | – sequence: 1 givenname: Hirofumi surname: Tomiyama fullname: Tomiyama, Hirofumi organization: From the Department of Cardiology and Division of Preemptive Medicine for Vascular Damage, Tokyo Medical University, Japan (H.T., K.S., Y.I., C.M., K.K., M.F., T.C., A.Y.) 1st Cardiology Department, Athens Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Greece (C.V.) – sequence: 2 givenname: Kazuki surname: Shiina fullname: Shiina, Kazuki – sequence: 3 givenname: Charalambos surname: Vlachopoulos fullname: Vlachopoulos, Charalambos – sequence: 4 givenname: Yoichi surname: Iwasaki fullname: Iwasaki, Yoichi – sequence: 5 givenname: Chisa surname: Matsumoto fullname: Matsumoto, Chisa – sequence: 6 givenname: Kazutaka surname: Kimura fullname: Kimura, Kazutaka – sequence: 7 givenname: Masatsune surname: Fujii fullname: Fujii, Masatsune – sequence: 8 givenname: Taishiro surname: Chikamori fullname: Chikamori, Taishiro – sequence: 9 givenname: Akira surname: Yamashina fullname: Yamashina, Akira |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29987103$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkU9v1DAQxS1U1G5LvwIKNy4B27ET-4DQqizsSlWL-kcqJ8tJJtTg2Fvb2arfHrPbvfTUw2ik0e-9Gc07RgfOO0DoA8GfCKnJ5-Wvn4urm8XF9eryYr6c56HIVUn8Bs0Ip6xkvK4O0AwTyUpJyN0ROo7xD8aEMdYcoiMqpWgIrmbo98ptvN3ACC4VfijmIUEw2hbXyQyDgxgL7fpi5Qarx1En411hXLF8WkOYgulgNLq8AqsT9MU32ID1673XFkrgYha9Q28HbSOcPvcTdPt9cXO2LM8vf6zO5udlx4TAJW_bpgIqW5JPF1y2nHUVNFSTXlQCWto3uGsEw0JjybnUtK9qSWhX16ITpK1O0Med7zr4hwliUqOJHVirHfgpKorrRghOuczo-2d0akfo1TqYUYcntX9OBr7ugC74GAMMqjNp-4IUtLGKYPU_DvUijjwUahtHdpAvHPZLXqP9stM-epsziX_t9AhB3YO26f4V-n-FdKXE |
CitedBy_id | crossref_primary_10_1096_fj_202402831R crossref_primary_10_1016_j_pcad_2019_11_002 crossref_primary_10_1111_jch_13707 crossref_primary_10_1161_HYPERTENSIONAHA_118_11496 crossref_primary_10_18632_aging_102130 crossref_primary_10_1093_ajh_hpaa030 crossref_primary_10_1093_ajh_hpaa130 crossref_primary_10_1167_iovs_62_10_12 crossref_primary_10_3390_ijms19123699 crossref_primary_10_1093_ajh_hpaa050 crossref_primary_10_5551_jat_RV17041 crossref_primary_10_1186_s13075_022_02933_4 crossref_primary_10_1161_JAHA_119_013004 crossref_primary_10_3389_fendo_2023_1131566 crossref_primary_10_3390_ijms22084071 crossref_primary_10_5551_jat_63544 crossref_primary_10_2147_JIR_S446342 crossref_primary_10_1097_HCO_0000000000000626 crossref_primary_10_14712_18059694_2019_132 crossref_primary_10_2147_VHRM_S355410 crossref_primary_10_23736_S2724_5683_24_06494_9 crossref_primary_10_1016_j_esxm_2020_100319 crossref_primary_10_3390_medicina58030373 crossref_primary_10_3389_fendo_2023_1197628 crossref_primary_10_1155_2019_7545137 crossref_primary_10_1097_MD_0000000000032327 crossref_primary_10_3389_fphar_2020_582680 crossref_primary_10_2459_JCM_0000000000000855 crossref_primary_10_1097_MD_0000000000037713 crossref_primary_10_3389_fcvm_2023_1105464 crossref_primary_10_3390_ijms20215301 crossref_primary_10_1016_j_molmet_2022_101549 crossref_primary_10_1038_s41598_024_83034_x crossref_primary_10_1161_HYPERTENSIONAHA_121_17584 crossref_primary_10_1038_s41440_019_0388_2 crossref_primary_10_1097_XCE_0000000000000300 crossref_primary_10_1038_s41440_020_0472_7 crossref_primary_10_3389_fphar_2020_00345 crossref_primary_10_3390_jcm11133779 crossref_primary_10_1038_s41440_023_01354_3 crossref_primary_10_1056_NEJMc2026125 crossref_primary_10_1136_bmjopen_2020_037842 crossref_primary_10_5551_jat_63099 crossref_primary_10_1055_a_1023_6710 crossref_primary_10_1038_s41440_022_00857_9 crossref_primary_10_1186_s12889_025_22064_0 crossref_primary_10_1186_s12944_020_01226_6 crossref_primary_10_12998_wjcc_v8_i11_2246 |
Cites_doi | 10.1177/1358863X10382946 10.1038/nrrheum.2014.124 10.1053/j.ajkd.2017.12.009 10.1038/ng.2876 10.1186/ar2761 10.1001/2012.jama.10503 10.1136/annrheumdis-2012-201916 10.1136/heartjnl-2012-302535 10.1186/ar3552 10.1253/circj.CJ-09-0534 10.1001/jama.290.22.2945 10.1002/acr.20344 10.1161/JAHA.117.005729 10.1097/HJH.0b013e32834f6a1d 10.1159/000464260 10.1053/j.ajkd.2010.02.344 10.1161/01.HYP.0000028589.66335.AA 10.1136/bmj.f4262 10.1161/HYPERTENSIONAHA.116.08114 10.1093/clinchem/47.3.444 10.33549/physiolres.931917 10.1161/hy1101.092839 10.1038/nrneph.2013.248 10.1291/hypres.25.359 10.1161/JAHA.117.008175 10.1161/HYPERTENSIONAHA.117.10370 10.1371/journal.pone.0067370 10.1371/journal.pone.0114259 10.1681/ASN.2014070660 |
ContentType | Journal Article |
Copyright | 2018 American Heart Association, Inc |
Copyright_xml | – notice: 2018 American Heart Association, Inc |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1161/HYPERTENSIONAHA.118.11390 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4563 |
EndPage | 745 |
ExternalDocumentID | 29987103 10_1161_HYPERTENSIONAHA_118_11390 10.1161/HYPERTENSIONAHA.118.11390 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .-D .XZ .Z2 01R 0R~ 18M 1J1 2WC 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AAXQO AAYEP ABASU ABBUW ABDIG ABJNI ABOCM ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADGGA ADHPY AE3 AE6 AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFNMH AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BCGUY BOYCO BQLVK C45 CS3 DIK DIWNM E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- GNXGY GQDEL GX1 H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JK3 K-A K-F K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B O9- OAG OAH OB3 ODMTH OGROG OHYEH OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OWBYB OWV OWW OWY OWZ OXXIT P2P PQQKQ RAH RIG RLZ S4R S4S TEORI TR2 TSPGW V2I VVN W3M W8F WH7 WOQ WOW X3V X3W XYM YFH YOC YYM ZFV .3C .55 .GJ 3O- AAYXX ADFPA ADGHP ADNKB AFFNX AHRYX AJNYG BS7 C1A CITATION DUNZO FW0 H13 JF9 JG8 JK8 N4W N~M OCUKA ODA ORVUJ OUVQU OWU OWX P-K R58 T8P X7M XXN YHZ YYP ZGI ZZMQN ACIJW AWKKM CGR CUY CVF ECM EIF NPM OLW RHF 7X8 |
ID | FETCH-LOGICAL-c4880-5bb73e29b1194859b54c3e72a1d838eb2d70c78408a09559a2d36912c668c81b3 |
ISSN | 0194-911X 1524-4563 |
IngestDate | Thu Jul 10 17:43:04 EDT 2025 Wed Feb 19 02:33:24 EST 2025 Thu Apr 24 22:52:37 EDT 2025 Tue Jul 01 01:44:55 EDT 2025 Fri May 16 03:49:59 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | blood pressure hyperuricemia risk factors inflammation hypertension |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4880-5bb73e29b1194859b54c3e72a1d838eb2d70c78408a09559a2d36912c668c81b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.118.11390 |
PMID | 29987103 |
PQID | 2067885259 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2067885259 pubmed_primary_29987103 crossref_citationtrail_10_1161_HYPERTENSIONAHA_118_11390 crossref_primary_10_1161_HYPERTENSIONAHA_118_11390 wolterskluwer_health_10_1161_HYPERTENSIONAHA_118_11390 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-09-01 |
PublicationDateYYYYMMDD | 2018-09-01 |
PublicationDate_xml | – month: 09 year: 2018 text: 2018-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Hypertension (Dallas, Tex. 1979) |
PublicationTitleAlternate | Hypertension |
PublicationYear | 2018 |
Publisher | American Heart Association, Inc |
Publisher_xml | – name: American Heart Association, Inc |
References | e_1_3_3_17_2 e_1_3_3_16_2 e_1_3_3_19_2 e_1_3_3_18_2 e_1_3_3_13_2 e_1_3_3_12_2 e_1_3_3_15_2 e_1_3_3_14_2 e_1_3_3_11_2 e_1_3_3_30_2 e_1_3_3_10_2 e_1_3_3_31_2 e_1_3_3_6_2 e_1_3_3_5_2 e_1_3_3_8_2 e_1_3_3_7_2 e_1_3_3_28_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_24_2 e_1_3_3_23_2 e_1_3_3_26_2 e_1_3_3_25_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_3_2 e_1_3_3_21_2 29987106 - Hypertension. 2018 Sep;72(3):582-584 |
References_xml | – ident: e_1_3_3_20_2 doi: 10.1177/1358863X10382946 – ident: e_1_3_3_31_2 doi: 10.1038/nrrheum.2014.124 – ident: e_1_3_3_7_2 doi: 10.1053/j.ajkd.2017.12.009 – ident: e_1_3_3_8_2 doi: 10.1038/ng.2876 – ident: e_1_3_3_25_2 doi: 10.1186/ar2761 – ident: e_1_3_3_16_2 doi: 10.1001/2012.jama.10503 – ident: e_1_3_3_27_2 doi: 10.1136/annrheumdis-2012-201916 – ident: e_1_3_3_6_2 doi: 10.1136/heartjnl-2012-302535 – ident: e_1_3_3_28_2 doi: 10.1186/ar3552 – ident: e_1_3_3_19_2 doi: 10.1253/circj.CJ-09-0534 – ident: e_1_3_3_18_2 doi: 10.1001/jama.290.22.2945 – ident: e_1_3_3_2_2 doi: 10.1002/acr.20344 – ident: e_1_3_3_9_2 doi: 10.1161/JAHA.117.005729 – ident: e_1_3_3_17_2 doi: 10.1097/HJH.0b013e32834f6a1d – ident: e_1_3_3_5_2 doi: 10.1159/000464260 – ident: e_1_3_3_14_2 doi: 10.1053/j.ajkd.2010.02.344 – ident: e_1_3_3_24_2 doi: 10.1161/01.HYP.0000028589.66335.AA – ident: e_1_3_3_30_2 doi: 10.1136/bmj.f4262 – ident: e_1_3_3_4_2 doi: 10.1161/HYPERTENSIONAHA.116.08114 – ident: e_1_3_3_12_2 doi: 10.1093/clinchem/47.3.444 – ident: e_1_3_3_21_2 doi: 10.33549/physiolres.931917 – ident: e_1_3_3_23_2 doi: 10.1161/hy1101.092839 – ident: e_1_3_3_22_2 doi: 10.1038/nrneph.2013.248 – ident: e_1_3_3_11_2 doi: 10.1291/hypres.25.359 – ident: e_1_3_3_10_2 doi: 10.1161/JAHA.117.008175 – ident: e_1_3_3_13_2 – ident: e_1_3_3_26_2 doi: 10.1161/HYPERTENSIONAHA.117.10370 – ident: e_1_3_3_15_2 doi: 10.1371/journal.pone.0067370 – ident: e_1_3_3_3_2 doi: 10.1371/journal.pone.0114259 – ident: e_1_3_3_29_2 doi: 10.1681/ASN.2014070660 – reference: 29987106 - Hypertension. 2018 Sep;72(3):582-584 |
SSID | ssj0014447 |
Score | 2.4957097 |
Snippet | This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of... |
SourceID | proquest pubmed crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 739 |
SubjectTerms | Adult Ankle Brachial Index Blood Pressure - physiology C-Reactive Protein - analysis Glomerular Filtration Rate - physiology Humans Hypertension - physiopathology Hyperuricemia - physiopathology Inflammation - physiopathology Male Middle Aged Odds Ratio Pulse Wave Analysis Risk Factors Uric Acid - blood Vascular Stiffness - physiology |
Title | Involvement of Arterial Stiffness and Inflammation in Hyperuricemia-Related Development of Hypertension |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29987103 https://www.proquest.com/docview/2067885259 |
Volume | 72 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1tb9MwELbKkCYQQrwNypsyiW8oY4kdx_lYwVAG2gSiQ92nyHEcFq1NpjXRYH-DP8ydk2beVkTZl6iyajfNcznfnZ-7I-QNgy2FSe25ngLfBHYMjq9U7nIeSQoGrNIB5jvv7fP4gH2aBJPB4LfFWmrqdEudL80ruQmqMAa4YpbsfyDbLwoD8BnwhSsgDNeVMN4tQbmYgt_mPH-E9EyMgH-rizw3Oqxl--YAe5uiiOGNGFzPU1NMaFZI17DhdGazh0xwH79k2O0dbp0Ba4-jdfoBA_Et1Uj_3HrrRWFkBRfG1az4JWfGQI0LUPnNrOhjOkdFsUhIO2-O-_HvU2zgclI102q-IARI-ANp1Zv_u2dyLtt-24dVoY4KO3bhiZ6cVVvpAhJresEztAXyGhEULFGGUjRZrvY5qv348MsOOAH7uAuN4hEMC2xZ07YjvVJVe4VZt8htH3wPbIvx-evF0RRjrMvBb29onWx2i73761KXjZ5rnsxdcu-sQnLE_NjkRlgWzvgBud-5Js6olbOHZKDLR2R9ryNfPCY_LHFzqtxZiJvTi5sD4ubY4uYUpbNU3BxL3HAtW6yekIOPO-P3sdv16XAVqn83SNOQaj9KPQ9rDUVpwBTVoS-9TFChUz8Lt1Uo2LaQpuCh9DPKI89XnAsFbhPdIGtlVepnxIkUzWiKBMjIZyFWw6OZyAKwofOQsSwcErF4kInqithjL5VpYpxZ7iVXMIBBkRgMhsTvp560lVxWmbS5QCsBvYuHabLUVTNPsO2BEIEfREPytIWxXxZMPAGWOx0SfgnXpM1t_vfPPr_pxBfkzsV79pKs1aeNfgVWc52-NlL8B6v3vjg |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Involvement+of+Arterial+Stiffness+and+Inflammation+in+Hyperuricemia-Related+Development+of+Hypertension&rft.jtitle=Hypertension+%28Dallas%2C+Tex.+1979%29&rft.au=Tomiyama%2C+Hirofumi&rft.au=Shiina%2C+Kazuki&rft.au=Vlachopoulos%2C+Charalambos&rft.au=Iwasaki%2C+Yoichi&rft.date=2018-09-01&rft.pub=American+Heart+Association%2C+Inc&rft.issn=0194-911X&rft_id=info:doi/10.1161%2FHYPERTENSIONAHA.118.11390&rft.externalDocID=10.1161%2FHYPERTENSIONAHA.118.11390 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0194-911X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0194-911X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0194-911X&client=summon |